
President Joseph R. Biden designated Rebecca Kelly Slaughter as Acting Chair of the Federal Trade Commission (FTC). Slaughter has served as a Commissioner since May 2018.
“I am deeply honored and grateful to lead an agency that is critical to helping the U.S. economy get back on its feet and function more fairly for all Americans,” Slaughter said. “I want to express my sincere appreciation for the excellent leadership of Chairman Simons during a time of unprecedented challenges.”
As a Commissioner, Slaughter has been an advocate for greater resources for the FTC and promoted equity and inclusion efforts. She has championed aggressive use of the FTC’s authorities. She has also been particularly outspoken about combating systemic racism, growing threats to competition, and the broad abuse of consumers’ data.
“The best part of serving at the FTC is working with our incredibly dedicated and talented staff. Their expertise, creativity, and steadfast commitment have filled me with confidence that we will be able to meet the formidable challenges facing our markets and the American people today,” Slaughter said of her new role.
Before joining the FTC, Chairwoman Slaughter served as Chief Counsel to Senator Charles Schumer of New York, the Senate Majority Leader.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas